Abstract
Periventricular leukomalacia (PVL) is a distinct form of brain injury that occurs in preterm infants. The aim of this study is to find suitable and easily accessible laboratory indicators for early prediction of PVL occurrence. A retrospective, case control study was conducted. Infants diagnosed with PVL were included and matched 1:3 with infants without PVL by sex and birth weight. A total of 364 infants were included in this study, including 91 in PVL group and 273 in control group. The hemoglobin (Hb) level (t = -2.961, p = 0.003) and red blood cell (RBC) count (t = -3.593, p < 0.001) in PVL group were lower than those in control group on the 7th day after birth. Logistic regression showed that the Hb level (OR = 0.984, 95%CI 0.972–0.996, p = 0.010) and the RBC count (OR = 0.120, 95%CI 0.034–0.424, p = 0.001) on the 7th day after birth were significantly correlated with the occurrence PVL disease. The receiver operating characteristic curve analysis showed that the cut-off value of Hb level on the 7th day after birth was 117.5 g/L (sensitivity = 0.553, specificity = 0.637) and the cut-off value of RBC count on the 7th day after birth was 3.025 × 1012/L (sensitivity = 0.762, specificity = 0.451). The specificities of the combined indicator on the 7th day after birth was 0.821. The Hb level and RBC count in early life can be used to predict the occurrence of PVL, which are suitable and easy to obtain.
Similar content being viewed by others
Introduction
Preterm and low birth weight (BW) infants have a high risk of injury to the immature and developing brain. Hemorrhage and periventricular leukomalacia (PVL) are the main types of brain injury affecting preterm infants1. PVL often occurs in preterm infants with gestational age (GA) of 24–32 weeks or very low birth weight2, potentially leading to sequelae in the nervous system, such as cerebral palsy3,4, visual disorders4,5 and dyskinesia6,7. With the development of neonatal intensive care units (NICUs) in recent years, the survival rate of preterm infants has increased, resulting in a significant increase in the incidence of nervous system sequelae associated with PVL8. PVL is usually asymptomatic until the obvious neurological sequelae manifest in the later period of infants. And once PVL occurs, there is no specific treatment. At present, researches on PVL mainly focus on the pathogenesis, clinical manifestations and imaging characteristics. Therefore, it is necessary to find suitable and easily accessible indicators for the early prediction of PVL occurrence.
Hypoxia-ischemia has long been considered one of the main mechanisms of perinatal brain injuries1,9. As a key protein for transporting oxygen in blood, hemoglobin (Hb) plays a significant role in regulating oxygen transport and maintaining cerebral perfusion10,11. In the rat model of hypoxia-ischemia-induced PVL, oligodendrocyte injury and myelinization disorders were observed12,13. Low Hb level may lead to insufficient oxygen supply in brain tissue, and then damage unmyelinated periventricular white matter sensitive to hypoxia14,15. At present, the clinical evidence about the relationship between Hb level and PVL is still limited, and the related mechanism is not completely clear. Thus, we conducted a retrospective case control study to analyze the relationship between Hb level in early life and PVL. This analysis aims to evaluate if Hb level can be used to predict the occurrence of PVL.
Methods
Study design
A retrospective, case control study was conducted in Children’s Hospital Affiliated to Zhengzhou University from January 2021 to December 2023. Infants with GA ≤ 32 weeks were included in the study. The exclusion criteria were as follows: (1) Congenital developmental malformation. (2) Congenital inherited metabolic diseases. (3) Congenital immune deficiency. (4) Lack of clinical data. Infants diagnosed with PVL were included in the PVL group and matched in a 1:3 ratio with infants without PVL by sex and BW. Infants without PVL were included in the control group. This study was approved by the ethics committee of Children’ s Hospital Affiliated to Zhengzhou University.
Data collection
Clinical data for each child, including baseline characteristics, neonatal comorbidities, maternal characteristics and blood routine test results in early life, were collected and analyzed. Baseline characteristics included gender, GA, BW, hospital stays, transfusion history, invasive mechanical ventilation (IMV) time and continuous positive airway pressure (CPAP) time. Maternal characteristics included maternal age, mode of delivery, multiple or singleton pregnancy, preterm rupture of membrane (PROM), pregnancy-induced hypertension syndrome (PIH), and placenta previa. Neonatal comorbidities included bronchopulmonary dysplasia (BPD), retinopathy of prematurity (ROP), intracranial hemorrhage (IVH), necrotizing enterocolitis (NEC), and sepsis. Blood routine test results included Hb level, red blood cell (RBC) count and platelet (PLT) count of infants on the 3rd, 7th and 14th day after birth. All preterm infants underwent routine blood tests on the 3rd, 7th and 14th day after birth. Blood samples were collected by experienced nurses in the early morning, and were examined by an automatic routine blood test instrument xe5000 (Shanghai, China, Sysmex company).
Definitions
PVL is defined as the presence of periventricular cysts identified on cranial ultrasound or cranial magnetic resonance imaging (MRI) scans16. PROM is defined as rupture of membranes before the onset of labor17. PIH is defined as new systolic and/or diastolic blood pressure ≥ 140/90 mmHg after 20 weeks of pregnancy, and postpartum blood pressure can return to normal18.
Placenta previa is defined as implantation of the placenta in the lower uterine segment partially or completely covering the internal cervical os after 20 weeks of gestation19. BPD is defined as the need for supplemental oxygen (FiO2 > 21%) for at least 28 days after birth20. ROP is defined as a developmental disorder of retinal vascular formation, and the stages are based on International Classification of Retinopathy of Prematurity21. IVH is a type of intracranial hemorrhage in premature infants, graded according to the Volpe classification based on cranial ultrasound findings14. NEC is an acute gastrointestinal disease characterized by variable degrees of intestinal wall inflammation and necrosis, and the staging is based on Bell staging standard22. Sepsis is defined as the disorder of host response caused by infection, which in turn leads to life-threatening organ dysfunction23. Blood transfusion standards are based on the Guideline for pediatric transfusion24.
Head imaging
Head ultrasound screening was performed 3–7 days after birth, at 40 weeks of corrected GA and before discharge25. The operation standard of brain ultrasound and the diagnosis of abnormal brain ultrasound results refer to the consensus of neonatal and infant brain ultrasound experts and Vries et al.26,27. For all hospitalized preterm infants, head MRI is recommended at 40 weeks of corrected GA25. All the preterm infants included in this study underwent head MRI examination at 40 weeks of corrected GA. A conventional MRI sequence protocol was applied in all of the infants: AX: T1WI (TR 400 ms, TE 8.1 ms), T2WI (TR 4500 ms, TE 99 ms), T2 Flair (TR 8000 ms, TE 105 ms). Sag: T1WI (TR200 ms, TE2.6 ms). Doctors who conducted the examination were unaware of the clinical condition of infants. We considered the classifications proposed by Vries et al., Choi et al. and Song et al. and classified PVL into three grades27,28,29. Grade I included local changes in the small capsule cavity around the ventricle. Grade II included extensive cystic changes around the ventricle, which could be fused into pieces. Grade III included cystic changes in the periventricular and subcortical white matter. As shown in Fig. 1.
Three grades of PVL on head MRI. (a). Grade I: local changes in the small capsule cavity around the ventricle (T2WI). (b). Grade II: extensive cystic changes around the ventricle, which could be fused into pieces (T2WI). (c). Grade III: cystic changes in the periventricular and subcortical white matter (T2WI). (d). Grade I: local changes in the small capsule cavity around the ventricle (T2 Flair). (e). Grade II: extensive cystic changes around the ventricle, which could be fused into pieces (T2 Flair). (f). Grade III: cystic changes in the periventricular and subcortical white matter (T2 Flair).
Statistical analysis
Statistical analysis was conducted using SPSS Version 26.0. Quantitative data (normal distribution) were presented as the mean ± standard deviation (mean ± SD), and the Student’s t test was used for group comparisons. Measurement data (nonnormally distributed) were expressed as medians, 25th percentiles and 75th percentiles (median [IQR]), and comparisons between groups were made using the Mann-Whitney U test. Count data were expressed as example (n, %), and comparisons between groups were performed using the Chi-square test. Logistic regression model was used to analyze the risk factors of PVL. Important confounding variables were identified from the literature and statistical results. Receiver operating characteristic (ROC) curve was used to analyze the correlation between the observed indicators and PVL occurrence. Binary logistic regression analysis was used to calculate the predicted value of combined indicators. Calculate odds ratios and 95% confidence intervals. Differences were considered statistically significant at p < 0.05. The raincloud plots were generated by the online platform named Weishengxin (https://www.bioinformatics.com.cn) to describe the distribution of hemoglobin level data. The heat map was generated by Origin Version 2021 to visualize the difference of baseline characteristics and neonatal complications between the two groups.
Results
Participants
A total of 364 infants were included in this study, including 91 in the PVL group and 273 in the control group. In the PVL group, 78.02% of the infants were male, with an average GA of 29.92 ± 1.63 weeks and an average BW of 1306.26 ± 221.86 g. In the control group, 78.02% of the infants were male, with an average GA of 30.49 ± 1.68 weeks and an average BW of 1341.94 ± 166.59 g. Compared with the control group, preterm infants in the PVL group had lower GA (t = −2.802, p = 0.005), longer hospital stays (t = 3.311, p = 0.001), more times of blood transfusion (u = 4.780, p < 0.001), longer IMV time (u = 2.399, p = 0.016) and longer CPAP time (u = 4.717, p < 0.001). Moreover, preterm infants in the PVL group were at higher risk of BPD (χ2 = 6.663, p = 0.010), ROP (χ2 = 8.051, p = 0.005), IVH III-IV (χ2 = 33.499, p < 0.001) and sepsis (χ2 = 5.801, p = 0.016) than those in the control group. In addition, there was no significant difference in sex, BW, multiple pregnancy, maternal age, pregnancy mode, PROM, PIH, placenta previa and II-III NEC between the two groups. As shown in Tables 1 and 2; Fig. 2.
Comparisons of blood routine test results
The Hb level of the two groups of preterm infants showed a downward trend early after birth. The Hb level of preterm infants in the PVL group was lower than that in the control group on the 3rd day (t = −3.210, p = 0.001) and the 7th day after birth (t = −2.961, p = 0.003). Similarly, the RBC count in the PVL group was lower than that in the control group on the 3rd day (t = −3.226, p = 0.001) and the 7th day after birth (t = −3.593, p < 0.001). However, the results were not statistically significant when comparing PLT count in early life between the two groups. The rain cloud map and the heat map showed the differences intuitively. As shown in Table 3; Figs. 2 and 3.
Risk factors and prediction of the occurrence of PVL
Multivariate logistic regression was used to analyze the risk factors of PVL. The results showed that the Hb level on the 7th day after birth (OR = 0.984, 95%CI 0.972–0.996, p = 0.010) and the RBC count on the 7th day after birth (OR = 0.120, 95%CI 0.034–0.424, p = 0.001) were significantly correlated with the occurrence PVL disease. In addition, IMV time (OR = 1.028, 95%CI 1.009–1.048, p = 0.004) and III-IV IVH (OR = 5.888, 95% CI 2.997–11.643, p < 0.001) were independent risk factors for PVL. As shown in Table 4.
The occurrence of PVL was predicted by the combined indicators of Hb level and RBC count. The ROC curve analysis showed that the cut-off value of Hb level on the 3rd day after birth was 140.5 g/L (sensitivity = 0.604, specificity = 0.582). The cut-off value of Hb level on the 7th day after birth was 117.5 g/L (sensitivity = 0.553, specificity = 0.637). The cut-off value of RBC count on the 3rd day after birth was 3.865 × 1012/L (sensitivity = 0.619, specificity = 0.615). The cut-off value of RBC count on the 7th day after birth was 3.025 × 1012/L (sensitivity = 0.762, specificity = 0.451). The sensitivities of combined indicators (Hb level and RBC count) on the 3rd day and 7th day after birth were 0.571 and 0.385, respectively. The specificities of combined index (Hb level and RBC count) on the 3rd day and 7th day after birth were 0.623 and 0.821, respectively. As shown in Table 5; Fig. 4.
Discussion
A retrospective, case control study was conducted on preterm infants with PVL. We found that the Hb level and RBC count on the 7th day after birth were significantly correlated with the occurrence PVL disease, and the Hb level combined with RBC count in the early life can be used to predict the occurrence of PVL. Therefore, our research provided two suitable and easily available laboratory indicators for clinicians to monitor and warn the occurrence of PVL at an early stage.
By analyzing the clinical data of the two groups, we found that preterm infants in the PVL group had smaller GA, more blood transfusion times, longer IMV and CPAP time, and higher incidence of BPD, III-IV IVH and sepsis, which was consistent with the findings of previous studies30,31,32,33. After eliminating confounding factors by logistic regression analysis, we found that long IMV time and III-IV IVH were independent risk factors for PVL. It has been confirmed in previous studies34,35,36,37. These factors are associated with hypoxia-ischemia and inflammatory mediators, which are the main pathogenesis of PVL38. The occurrence of PVL is mainly related to oligodendrocytes (OLs) of myelin sheath on nerve fiber axons. During brain development of preterm infants, immature OLs are in the stage of premyelinating oligodendrocytes, which have been confirmed to be susceptible to hypoxia-ischemia and inflammatory mediators39,40,41,42. Free radicals, excitatory amino acids and cytokines produced by ischemia-reperfusion, oxidative stress and inflammatory reaction can induce cell death through apoptotic mechanisms, thereby contributing to nerve axon injury43,44,45. However, our study did not find significant differences in pregnancy risk factors between the two groups, possibly due to the limited sample size.
Hb levels of the two groups of preterm infants showed a downward trend early after birth, which may be associated with the increase of oxygen saturation and the decrease of erythropoietin (EPO) level46. The hematopoietic function of preterm infants is not yet mature. The oxygen-enriched environment after birth reduces the production of EPO and accelerates its catabolism. These factors lead to insufficient erythropoiesis, and preterm infants are prone to physiological anemia early after birth47,48. In addition, the life span of red blood cells in preterm infants is short (about 60–70 days), and they are more likely to be destroyed under the conditions of hyperoxia exposure and oxidative stress, which aggravates anemia49. What’s more, the blood routine test of preterm infants in NICU after birth may have a significant impact on very low birth weight infants, which is also one of the main ways of iatrogenic anemia50.
We found that the Hb level and RBC count on the 3rd and 7th day after birth in the PVL group were lower than those in the control group. However, there were no significant differences in the Hb level and RBC count between the two groups on the 14th day after birth, with all measurements remaining at low levels. After eliminating confounding factors by logistic regression analysis, our study found that high Hb level and RBC count on the 7th day after birth can reduce the risk of the occurrence of PVL. Although this has rarely been analyzed in previous studies and there is a lack of relevant clinical literature reports, the correlation between Hb level and hypoxia-ischemia has drawn our attention to this aspect. Hb is the main carrier of oxygen in the human body, which can reversibly combine with oxygen molecules to generate oxygenated Hb and then transport oxygen to tissues10. The decrease of Hb level leads to anemia. As an important inducement of cerebral hypoperfusion, anemia may lead to chronic hypoxia of white matter by reducing the oxygen transport efficiency of brain tissue. At the same time, cerebral blood flow is more likely to fluctuate under anemia, which increases the risk of ischemia-reperfusion injury and then causes PVL1,39,51. This difference was not significant on the 14th day after birth. We inferred that continuous clinical treatment and intervention measures were helpful to improve the general condition of preterm infants and promote the recovery of their hematopoietic function. PVL usually occurs after birth. The early ultrasound manifestations of PVL were strong brain echo (on the 3rd to the 10th day after birth)16. This is consistent with our findings. Previous studies have shown that Hb is associated with HIE in term infants52,53. PVL is one of the manifestations of hypoxic-ischemic brain injury in preterm infants. Our findings suggested that Hb also played a significant role in hypoxic-ischemic brain injury in preterm infants.
Our study found that the Hb level and RBC count in early life can be used to predict the occurrence of PVL. The sensitivity and specificity of the Hb level on the 7th day after birth for predicting the occurrence of PVL were 0.553 and 0.637, respectively. The cut-off value was 117.5 g/L. The sensitivity and specificity of the RBC count on the 7th day after birth for predicting the occurrence of PVL were 0.762 and 0.451, respectively. The cut-off value was 3.025 × 1012/L. Additionally, the use of combined indicators (Hb level combined with RBC count) enhanced the specificity of the prediction. We found that the specificity of combined indicators on the 7th day after birth was 0.821. Although hematologic measurements within 14 days after birth are influenced by numerous factors, such as iatrogenic losses and blood transfusions, we believe that these hematological measurements still have potential predictive value. On one hand, we incorporated several confounding factors into the regression model to reduce the influence. On the other hand, the alteration of these parameters also reflected the overall oxygen transport status of preterm infants early after birth and the comprehensive influence of early clinical treatment. We suggest that the Hb level and the RBC count should be used as practical auxiliary indicators, especially when neuroimaging and clinical risk factors are considered, to predict the occurrence of PVL at an early stage.
Our study had limitations. First, we did not conduct long-term follow-up of preterm infants in both the PVL group and the control group, and lacked the comparison of neurodevelopmental outcomes between the two groups. Second, the data were obtained from a single tertiary hospital, which potentially limits the generalizability of our results to lower-level medical centers. Finally, we lacked joint analysis of multi-center data. Further comprehensive researches are needed to verify our findings.
Conclusions
We found that the Hb level and RBC count on the 7th day after birth were significantly correlated with the occurrence PVL disease. And low Hb level and low RBC count on the 7th day after birth can jointly predict the occurrence of PVL. Our study provides clinicians with two suitable, easily accessible laboratory indicators for early warning of the occurrence of PVL. Clinicians should strengthen the monitoring of Hb level and RBC count of preterm infants in early life, and select screening time for PVL reasonably and timely. Taking effective prevention and treatment measures as early as possible may contribute to improving brain development outcomes in preterm infants.
Data availability
The datasets used and analyzed during the study are included in this published article.
Abbreviations
- PVL:
-
Periventricular leukomalacia
- NICU:
-
Neonatal intensive care unit
- GA:
-
Gestational age
- MRI:
-
Magnetic Resonance Imaging
- BW:
-
Birth weight
- IMV:
-
Invasive mechanical ventilation
- CPAP:
-
Continuous positive airway pressure
- PROM:
-
Preterm rupture of membrane
- PIH:
-
Pregnancy-induced hypertension syndrome
- BPD:
-
Bronchopulmonary dysplasia
- ROP:
-
Retinopathy of prematurity
- IVH:
-
Intracranial hemorrhage
- NEC:
-
Necrotizing enterocolitis
- Hb:
-
Hemoglobin
- RBC:
-
Red blood cell
- PLT:
-
Platelet
- ROC:
-
Receiver operating characteristic
- OL:
-
Oligodendrocytes
- EPO:
-
Erythropoietin
References
Lee, Y. A. White matter injury of prematurity: its mechanisms and clinical features. J. Pathol. Transl Med. 51 (5), 449–455 (2017).
Pascal, A. et al. The impact of intraventricular hemorrhage and periventricular leukomalacia on mortality and neurodevelopmental outcome in very preterm and very low birthweight infants: A prospective Population-based cohort study. J. Pediatr. 262, 113600 (2023).
Reddy, N. et al. Neuroradiological mimics of periventricular leukomalacia. J. Child. Neurol. 37 (2), 151–167 (2022).
Tinelli, F. et al. Structural brain damage and visual disorders in children with cerebral palsy due to periventricular leukomalacia. Neuroimage Clin. 28, 102430 (2020).
Petri, S. & Tinelli, F. Visual impairment and periventricular leukomalacia in children: A systematic review. Res. Dev. Disabil. 135, 104439 (2023).
Outsika, C. et al. Bradykinesia assessment in children with cerebral palsy and periventricular leukomalacia. Eur. J. Paediatr. Neurol. 42, 71–74 (2023).
Ueda, K., Aravamuthan, B. R. & Pearson, T. S. Dystonia in individuals with spastic cerebral palsy and isolated periventricular leukomalacia. Dev. Med. Child. Neurol. 65 (1), 94–99 (2023).
Cao, Y. et al. Assessment of neonatal intensive care unit practices, morbidity, and mortality among very preterm infants in China. JAMA Netw. Open. 4(8), e2118904, 1–13 (2021).
Huang, J. et al. Association between perinatal hypoxic-ischemia and periventricular leukomalacia in preterm infants: A systematic review and meta-analysis. PLoS One 12(9), e0184993, 1–15 (2017).
Ciaccio, C., Coletta, A. & Coletta, M. Role of hemoglobin structural-functional relationships in oxygen transport. Mol. Aspects Med. 84, 101022 (2022).
Godoy, D. A., Rubiano, A. M., Paranhos, J., Robba, C. & Lazaridis, C. Avoiding brain hypoxia in severe traumatic brain injury in settings with limited resources - A pathophysiological guide. J. Crit. Care. 75, 154260 (2023).
Qiao, L. et al. Neuronalinjury and roles of apoptosis and autophagy in a neonatal rat model of hypoxia-ischemia-induced periventricular leukomalacia. Mol. Med. Rep. 17 (4), 5940–5949 (2018).
Caprariello, A. V. et al. Apoptosis of oligodendrocytes during early development delays myelination and impairs subsequent responses to demyelination. J. Neurosci. 35 (41), 14031–14041 (2015).
Volpe, J. J. Neurology of the Newborn 5th edn (Saunders Elsevier, 2008).
Kalteren, W. S., Verhagen, E. A., Mintzer, J. P., Bos, A. F. & Kooi, E. M. W. Anemia and red blood cell transfusions, cerebral oxygenation, brain injury and development, and neurodevelopmental outcome in preterm infants: A systematic review. Front. Pediatr. 9, 644462 (2021).
Agut, T. et al. Preterm white matter injury: ultrasound diagnosis and classification. Pediatr. Res. 87 (Suppl 1), 37–49 (2020).
Siegler, Y., Weiner, Z. & Solt, I. ACOG practice bulletin 217: prelabor rupture of membranes. Obstet. Gynecol. 136 (5), 1061 (2020).
Gestational Hypertension and Preeclampsia. ACOG practice bulletin, number 222. Obstet. Gynecol. 135 (6), e237–e260 (2020).
Jauniaux, E. et al. Placenta Praevia and placenta accreta: diagnosis and management: Green-top guideline no. 27a. Bjog 126 (1), e1–e48 (2019).
Jobe, A. H. & Bancalari, E. Bronchopulmonary dysplasia. Am. J. Respir Crit. Care Med. 163 (7), 1723–1729 (2001).
Chiang, M. F. et al. International classification of retinopathy of prematurity, third edition. Ophthalmology 128 (10), e51–e68 (2021).
Bell, M. J. et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann. Surg. 187 (1), 1–7 (1978).
Shane, A. L., Sánchez, P. J. & Stoll, B. J. Neonatal sepsis. Lancet 390 (10104), 1770–1780 (2017).
Gui, R. et al. Explanation and interpretation of the compilation of neonatal blood transfusion in the National health standard guideline for pediatric transfusion. Chin. J. Pediatr. 26 (12), 1249–1254 (2024).
Feng, Z., Liu, J., Yu, H. & Mao, J. Expert consensus on diagnosis, prevention and treatment of brain injury in preterm infants. Chin. J. Pediatr. 14 (12), 883–884 (2012).
Ultrasound Medicine Professional Committee of China Medical Education Association and Ultrasound Medicine Preparatory Group of Chinese Medical Association. Expert consensus on neonatal and infant cranial ultrasound. Chin. J. Med. Ultrasound. 18 (6), 534–542 (2021).
de Vries, L. S., Eken, P. & Dubowitz, L. M. The spectrum of leukomalacia using cranial ultrasound. Behav. Brain Res. 49 (1), 1–6 (1992).
Choi, J. Y., Rha, D. W. & Park, E. S. The effects of the severity of periventricular leukomalacia on the neuropsychological outcomes of preterm children. J. Child. Neurol. 31 (5), 603–612 (2016).
Song, J. et al. Clinical characteristics and long-term neurodevelopmental outcomes of leukomalacia in preterm infants and term infants: a cohort study. J. Neurodev Disord. 15 (1), 24 (2023).
Ohlsson, A. & Aher, S. M. Early erythropoiesis-stimulating agents in preterm or low birth weight infants. Cochrane Database Syst. Rev. 2 (2), Cd004863 (2020).
Wang, L. W., Lin, Y. C., Tu, Y. F., Wang, S. T. & Huang, C. C. Isolated cystic periventricular leukomalacia differs from cystic periventricular leukomalacia with intraventricular hemorrhage in prevalence, risk factors and outcomes in preterm infants. Neonatology 111 (1), 86–92 (2017).
Jiang, S. et al. Epidemiology and microbiology of late-onset sepsis among preterm infants in china, 2015–2018: A cohort study. Int. J. Infect. Dis. 96, 1–9 (2020).
Wang, L. W., Lin, Y. C., Wang, S. T. & Huang, C. C. Identifying risk factors shared by bronchopulmonary dysplasia, severe retinopathy, and cystic periventricular leukomalacia in very preterm infants for targeted intervention. Neonatology 114 (1), 17–24 (2018).
Hatzidaki, E. et al. Risk factors for periventricular leukomalacia. Acta Obstet. Gynecol. Scand. 88 (1), 110–115 (2009).
Trounce, J. Q., Shaw, D. E., Levene, M. I. & Rutter, N. Clinical risk factors and periventricular leucomalacia. Arch. Dis. Child. 63 (1), 17–22 (1988).
Volpe, J. J. Neurobiology of periventricular leukomalacia in the premature infant. Pediatr. Res. 50 (5), 553–562 (2001).
Hamrick, S. E. et al. Trends in severe brain injury and neurodevelopmental outcome in premature newborn infants: the role of cystic periventricular leukomalacia. J. Pediatr. 145 (5), 593–599 (2004).
Cerisola, A., Baltar, F., Ferrán, C. & Turcatti, E. Mechanisms of brain injury of the premature baby]. Med. (B Aires. 79 (Suppl 3), 10–14 (2019).
Volpe, J. J. Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet Neurol. 8 (1), 110–124 (2009).
Zaghloul, N., Patel, H. & Ahmed, M. N. A model of periventricular leukomalacia (PVL) in neonate mice with histopathological and neurodevelopmental outcomes mimicking human PVL in neonates. PLoS One 12(4), e0175438, 1–15 (2017).
Back, S. A. White matter injury in the preterm infant: pathology and mechanisms. Acta Neuropathol. 134 (3), 331–349 (2017).
Nemes-Baran, A. D., White, D. R. & DeSilva, T. M. Fractalkine-Dependent microglial pruning of viable oligodendrocyte progenitor cells regulates myelination. Cell. Rep. 32 (7), 108047 (2020).
Lembo, C., Buonocore, G. & Perrone, S. Oxidative stress in preterm newborns. Antioxid. (Basel). 10 (11), 1672 (2021).
Beeraka, N. M. et al. Recent investigations on neurotransmitters’ role in acute white matter injury of perinatal glia and Pharmacotherapies-Glia dynamics in stem cell therapy. Mol. Neurobiol. 59 (4), 2009–2026 (2022).
Ortega, S. B. et al. Perinatal chronic hypoxia induces cortical inflammation, hypomyelination, and peripheral myelin-specific T cell autoreactivity. J. Leukoc. Biol. 99 (1), 21–29 (2016).
Jorgensen, J. M., Crespo-Bellido, M. & Dewey, K. G. Variation in hemoglobin across the life cycle and between males and females. Ann. N Y Acad. Sci. 1450 (1), 105–125 (2019).
Colombatti, R., Sainati, L. & Trevisanuto, D. Anemia and transfusion in the neonate. Semin Fetal Neonatal Med. 21 (1), 2–9 (2016).
Kitaoka, H. et al. Risk factors for anemia of prematurity among 30-35-week preterm infants. Fukushima J. Med. Sci. 69 (2), 115–123 (2023).
Juul, S. Erythropoiesis and the approach to anemia in premature infants. J. Matern Fetal Neonatal Med. 25 (Suppl 5), 97–99 (2012).
Strauss, R. G. Anaemia of prematurity: pathophysiology and treatment. Blood Rev. 24 (6), 221–225 (2010).
Rajaram, A. et al. Assessing cerebral blood flow, oxygenation and cytochrome c oxidase stability in preterm infants during the first 3 days after birth. Sci. Rep. 12 (1), 181 (2022).
Katheria, A. C. et al. Umbilical cord milking in nonvigorous infants: a cluster-randomized crossover trial. Am. J. Obstet. Gynecol. 228 (2), e211–e214 (2023).
Costescu, O. C. et al. Early postnatal administration of erythropoietin and its association with neurodevelopmental outcomes and incidence of intraventricular hemorrhage and Hypoxic-Ischemic encephalopathy: A Four-Week observational study. Pediatr. Rep. 16 (2), 339–352 (2024).
Acknowledgements
The participation of all the infants and their parents or legal guardians in this study is greatly appreciated.
Funding
This work was provided by Henan Provincial Health Commission (YXKC2021022).
Author information
Authors and Affiliations
Contributions
Concept and study design: HS and MY. Data acquisition and analysis: ZS, LH and CZ. Drafting of the manuscript and figures: MY. All authors approved the final manuscript as submitted and agreed to be accountable for all aspects of the work.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics approval and consent to participate
All methods were performed in accordance with the ethical standards of the Declaration of Helsinki and its later amendments or comparable ethical standards. This study was approved by the National Children’s Regional Medical Center, Henan Children’s Medical Center, and Henan Pediatric Disease Clinical Medical Research Center.
Informed consent
has obtained from a parent and/or legal guardian.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Yu, M., Sun, Z., He, L. et al. The effect of hemoglobin level in early life on periventricular leukomalacia: a case control study. Sci Rep 15, 31748 (2025). https://doi.org/10.1038/s41598-025-13696-8
Received:
Accepted:
Published:
Version of record:
DOI: https://doi.org/10.1038/s41598-025-13696-8






